List of Tables
Table 1. Global Leuprorelin Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Leuprorelin Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Leuprorelin Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Leuprorelin Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Leuprorelin Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Leuprorelin Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Leuprorelin Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Leuprorelin Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Leuprorelin Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Leuprorelin Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Leuprorelin Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Leuprorelin Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Leuprorelin Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Leuprorelin Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Leuprorelin Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Leuprorelin Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Leuprorelin Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Leuprorelin Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Leuprorelin Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Leuprorelin Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Leuprorelin Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Leuprorelin Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Leuprorelin Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Leuprorelin Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Leuprorelin Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Leuprorelin Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Leuprorelin Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Leuprorelin Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Leuprorelin Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Leuprorelin Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Leuprorelin Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Leuprorelin Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Leuprorelin Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Leuprorelin Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Leuprorelin Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Leuprorelin Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Leuprorelin Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Leuprorelin Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Leuprorelin Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Leuprorelin Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Leuprorelin Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Leuprorelin Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Leuprorelin Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Leuprorelin Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Leuprorelin Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Leuprorelin Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Leuprorelin Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Leuprorelin Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Leuprorelin Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Leuprorelin Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Leuprorelin Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Leuprorelin Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Leuprorelin Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Leuprorelin Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Leuprorelin Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Leuprorelin Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Leuprorelin Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Leuprorelin Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Leuprorelin Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Leuprorelin Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Leuprorelin Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Leuprorelin Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Leuprorelin Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Leuprorelin Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Leuprorelin Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Leuprorelin Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Leuprorelin Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Leuprorelin Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Takeda Pharmaceutical Company Information
Table 71. Takeda Pharmaceutical Description and Business Overview
Table 72. Takeda Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Takeda Pharmaceutical Leuprorelin Drugs Product
Table 74. Takeda Pharmaceutical Recent Developments/Updates
Table 75. AbbVie Company Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AbbVie Leuprorelin Drugs Product
Table 79. AbbVie Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Merck Leuprorelin Drugs Product
Table 84. Merck Recent Developments/Updates
Table 85. Sun Pharmaceutical Company Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sun Pharmaceutical Leuprorelin Drugs Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Eugia Pharma Company Information
Table 91. Eugia Pharma Description and Business Overview
Table 92. Eugia Pharma Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Eugia Pharma Leuprorelin Drugs Product
Table 94. Eugia Pharma Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Cipla Leuprorelin Drugs Product
Table 99. Cipla Recent Developments/Updates
Table 100. Tolmar Company Information
Table 101. Tolmar Description and Business Overview
Table 102. Tolmar Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Tolmar Leuprorelin Drugs Product
Table 104. Tolmar Recent Developments/Updates
Table 105. Accord BioPharma Company Information
Table 106. Accord BioPharma Description and Business Overview
Table 107. Accord BioPharma Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Accord BioPharma Leuprorelin Drugs Product
Table 109. Accord BioPharma Recent Developments/Updates
Table 110. Foresee Pharmaceuticals Company Information
Table 111. Foresee Pharmaceuticals Description and Business Overview
Table 112. Foresee Pharmaceuticals Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Foresee Pharmaceuticals Leuprorelin Drugs Product
Table 114. Foresee Pharmaceuticals Recent Developments/Updates
Table 115. Beijing Biote Pharmaceutical Company Information
Table 116. Beijing Biote Pharmaceutical Description and Business Overview
Table 117. Beijing Biote Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Beijing Biote Pharmaceutical Leuprorelin Drugs Product
Table 119. Beijing Biote Pharmaceutical Recent Developments/Updates
Table 120. Livzon Pharmaceutical Company Information
Table 121. Livzon Pharmaceutical Description and Business Overview
Table 122. Livzon Pharmaceutical Leuprorelin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Livzon Pharmaceutical Leuprorelin Drugs Product
Table 124. Livzon Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Leuprorelin Drugs Distributors List
Table 128. Leuprorelin Drugs Customers List
Table 129. Leuprorelin Drugs Market Trends
Table 130. Leuprorelin Drugs Market Drivers
Table 131. Leuprorelin Drugs Market Challenges
Table 132. Leuprorelin Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Leuprorelin Drugs
Figure 2. Global Leuprorelin Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Leuprorelin Drugs Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Injections Product Picture
Figure 6. Implants Product Picture
Figure 7. Global Leuprorelin Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Leuprorelin Drugs Market Share by Application: 2025 & 2032
Figure 9. Central Precocious Puberty
Figure 10. Advanced Prostate Cancer
Figure 11. Uterine Fibroids
Figure 12. Endometriosis
Figure 13. Other
Figure 14. Global Leuprorelin Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Leuprorelin Drugs Market Size (US$ Million), 2021–2032
Figure 16. Global Leuprorelin Drugs Sales (K Units), 2021–2032
Figure 17. Global Leuprorelin Drugs Average Price (US$/Unit), 2021–2032
Figure 18. Leuprorelin Drugs Report Years Considered
Figure 19. Leuprorelin Drugs Sales Share by Manufacturers in 2025
Figure 20. Global Leuprorelin Drugs Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Leuprorelin Drugs Players: Market Share by Revenue in Leuprorelin Drugs in 2025
Figure 22. Leuprorelin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Leuprorelin Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Leuprorelin Drugs Sales Market Share by Country (2021–2032)
Figure 25. North America Leuprorelin Drugs Revenue Market Share by Country (2021–2032)
Figure 26. United States Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Leuprorelin Drugs Sales Market Share by Country (2021–2032)
Figure 29. Europe Leuprorelin Drugs Revenue Market Share by Country (2021–2032)
Figure 30. Germany Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Leuprorelin Drugs Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Leuprorelin Drugs Revenue Market Share by Region (2021–2032)
Figure 37. China Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Leuprorelin Drugs Sales Market Share by Country (2021–2032)
Figure 45. Latin America Leuprorelin Drugs Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Leuprorelin Drugs Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Leuprorelin Drugs Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Leuprorelin Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Leuprorelin Drugs by Type (2021–2032)
Figure 56. Global Revenue Market Share of Leuprorelin Drugs by Type (2021–2032)
Figure 57. Global Leuprorelin Drugs Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Leuprorelin Drugs by Application (2021–2032)
Figure 59. Global Revenue Market Share of Leuprorelin Drugs by Application (2021–2032)
Figure 60. Global Leuprorelin Drugs Price (US$/Unit) by Application (2021–2032)
Figure 61. Leuprorelin Drugs Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
